Donald Trump has threatened to introduce tariffs of up to 200pc on pharmaceutical imports in a bid to force more drugmakers to bring factories to the US.

Donald Trump has threatened to introduce tariffs of up to 200pc on pharmaceutical imports in a bid to force more drugmakers to bring factories to the US.

On Tuesday, the US President said “very, very high” duties could be imposed on medicines imported into the US but that he was considering giving pharmaceutical groups one year “to get their act together.”

Economists have warned that higher tariffs on drugs would also hurt American patients, and that taxpayers would end up having to pay more for US government healthcare schemes.

  • fullsquare@awful.systems
    3·
    6 days ago

    No. Barrels of API (active pharmaceutical ingredient) are mostly hauled from India or China, then formulated into pills or whatever, this goes especially for generic medicines. There is some american manufacture of APIs, but these tend to be on more expensive side (biologicals or small molecule drugs under patent). Inputs for these APIs also tend to be made in India or China